So DiMarchi started creating drugs that targeted both GLP-1 and glucagon receptors
Genetic polymorphisms in NAT2 (N-acetyltransferase 2), TPMT (thiopurine methyltransferase), and glutathione S-transferase genes create phenotypic differences
Turton MD, OShea D, Gunn I, Beak SA, Edwards CM, Meeran K, et al
Deletion of cytoplasmic neutral lipids in RA-monocytes resulted in a red intensity that was 1.74-fold lower in RA monocytes than in those from HCs, suggesting either impaired lipid synthesis or enhanced FAO in RA monocytes ( Figures 1B, C )
The peptide interacts with fat metabolism pathways that follow circadian rhythms and respond to nutritional status
PubMed laboratory research record [PMID: 10067662] PubMed record related to this compound for laboratory literature review